102 related articles for article (PubMed ID: 23452677)
41. [Decreasing reperfusion damage with N-acetylcysteine in experimental pancreas transplantion].
Mayer H; Thies J; Schmidt J; Gebhard MM; Herfarth C; Klar E
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):147-51. PubMed ID: 14518230
[TBL] [Abstract][Full Text] [Related]
42. Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery.
Kim JC; Hong SW; Shim JK; Yoo KJ; Chun DH; Kwak YL
Acta Anaesthesiol Scand; 2011 Apr; 55(4):452-9. PubMed ID: 21391924
[TBL] [Abstract][Full Text] [Related]
43. Supplement may ease compulsive hair pulling.
Harv Ment Health Lett; 2009 Oct; 26(4):7. PubMed ID: 19911455
[No Abstract] [Full Text] [Related]
44. Oxcarbazepine for the treatment of trichotillomania.
Leombruni P; Gastaldi F
Clin Neuropharmacol; 2010; 33(2):107-8. PubMed ID: 20375658
[TBL] [Abstract][Full Text] [Related]
45. Effects of N-acetylcysteine and L-arginine in the antioxidant system of C2C12 cells.
Da Silva EP; Lambertucci RH
J Sports Med Phys Fitness; 2015 Jun; 55(6):691-9. PubMed ID: 26205767
[TBL] [Abstract][Full Text] [Related]
46. Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes.
Whillier S; Raftos JE; Chapman B; Kuchel PW
Redox Rep; 2009; 14(3):115-24. PubMed ID: 19490753
[TBL] [Abstract][Full Text] [Related]
47. N -acetylcysteine for Trichotemnomania in an Adult Female With Williams Syndrome.
Carroll HM; McDougle CJ; Thom RP
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):321-323. PubMed ID: 38497565
[No Abstract] [Full Text] [Related]
48. Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report.
Golubchik P; Sever J; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(3):108-10. PubMed ID: 21586916
[TBL] [Abstract][Full Text] [Related]
49. RSH ANTIOXIDANTS INCREASE INTRACELLULAR ROS LEVEL AND PROLIFERATION OF SP2/0 MYELOMA CELLS IN SERUM-FREE MEDIUM.
Tabakov VY; Veiko NN; Chestkov VV; Kostyuk SV
Tsitologiia; 2016; 58(12):924-9. PubMed ID: 30188108
[TBL] [Abstract][Full Text] [Related]
50. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.
Aldini G; Altomare A; Baron G; Vistoli G; Carini M; Borsani L; Sergio F
Free Radic Res; 2018 Jul; 52(7):751-762. PubMed ID: 29742938
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of oral N -acetylcysteine in a rat experimental model of asthma.
Blesa S; Cortijo J; Martinez-Losa M; Mata M; Seda E; Santangelo F; Morcillo EJ
Pharmacol Res; 2002 Feb; 45(2):135-40. PubMed ID: 11846626
[TBL] [Abstract][Full Text] [Related]
52. Improvement of hepatic microhemodynamics by N-acetylcysteine after warm ischemia.
Koeppel TA; Thies JC; Lehmann T; Gebhard MM; Herfarth C; Otto G; Post S
Eur Surg Res; 1996; 28(4):270-7. PubMed ID: 8813651
[TBL] [Abstract][Full Text] [Related]
53. Experimental study of the rat for the assessment of barium coating on the gastric mucosa: efficacy of ranitidine and acetylcysteine administration.
Sugino Y; Semmler W
Radiat Med; 2004; 22(3):173-8. PubMed ID: 15287533
[TBL] [Abstract][Full Text] [Related]
54. N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice.
Herrmann AP; Benvenutti R; Pilz LK; Elisabetsky E
Schizophr Res; 2014 May; 155(1-3):109-11. PubMed ID: 24725851
[TBL] [Abstract][Full Text] [Related]
55. Prevention of gentamicin ototoxicity with N-acetylcysteine and vitamin A.
Aladag I; Guven M; Songu M
J Laryngol Otol; 2016 May; 130(5):440-6. PubMed ID: 27095551
[TBL] [Abstract][Full Text] [Related]
56. [N-acetylcysteine reduces transformed 3T3-SV40 fibroblast sensitivity to lysis by natural killer cells].
Filatova NA; Kirpichnikova KM; Gamaleĭ IA
Tsitologiia; 2006; 48(5):438-42. PubMed ID: 16892853
[TBL] [Abstract][Full Text] [Related]
57. The effect of N-acetylcysteine on exercise-induced priming of human neutrophils. A chemiluminescence study.
Huupponen MR; Mäkinen LH; Hyvönen PM; Sen CK; Rankinen T; Väisänen S; Rauramaa R
Int J Sports Med; 1995 Aug; 16(6):399-403. PubMed ID: 7591392
[TBL] [Abstract][Full Text] [Related]
58. N-acetylcysteine: multiple clinical applications.
Millea PJ
Am Fam Physician; 2009 Aug; 80(3):265-9. PubMed ID: 19621836
[TBL] [Abstract][Full Text] [Related]
59. The antioxidant acetylcysteine reduces oxidative stress by decreasing level of AOPPs.
Lazárová M; Stejskal D; Lacnák B; Václavík J; Adamovská S; Ochmanová R; Hanák V; Skácelová M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Dec; 148(2):131-3. PubMed ID: 15744360
[TBL] [Abstract][Full Text] [Related]
60. A controlled trial of venlafaxine in trichotillomania: interim phase I results.
Ninan PT; Knight B; Kirk L; Rothbaum BO; Kelsey J; Nemeroff CB
Psychopharmacol Bull; 1998; 34(2):221-4. PubMed ID: 9641004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
